ZNF223 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 3.22940008068429E-10 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.216390E-04 |
Normal-vs-Stage2 |
8.03940000000392E-05 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
6.162500E-03 |
Stage1-vs-Stage2 |
6.957200E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.118800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.857400E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.0674999995075E-08 |
Normal-vs-AfricanAmerican |
1.611210E-01 |
Normal-vs-Asian |
8.304400E-02 |
Caucasian-vs-AfricanAmerican |
2.732100E-02 |
Caucasian-vs-Asian |
9.629000E-01 |
AfricanAmerican-vs-Asian |
1.297410E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.760700E-04 |
Normal-vs-Female |
1.45939999973699E-07 |
Male-vs-Female |
3.775200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.322800E-03 |
Normal-vs-Extreme_Weight |
3.67370000000644E-05 |
Normal-vs-Obese |
2.158400E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.175600E-01 |
Normal_Weight-vs-Obese |
3.093900E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.371580E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.239600E-01 |
Normal-vs-Age(41-60Yrs) |
4.924500E-03 |
Normal-vs-Age(61-80Yrs) |
1.07309999997085E-07 |
Normal-vs-Age(81-100Yrs) |
3.228400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.093000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.140500E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.986200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.735000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.833200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.495200E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.161200E-01 |
Normal-vs-Grade 3 |
6.247600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.008600E-01 |
Grade 2-vs-Grade 4 |
6.161200E-01 |
Grade 3-vs-Grade 4 |
6.247600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.11510000011528E-07 |
Normal-vs-N1 |
5.942800E-03 |
N0-vs-N1 |
8.402400E-02 |
|
|